Find Suppliers of Controlled & Modified Release Excipients For Tablet

01

Evonik

Germany

CPhI WW Frankfurt

Booth #6.1B44

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Tablet

Grade : Oral

Brand Name : EUDRAGIT® E 100

Application : Controlled & Modified Release

Excipient Details : EUDRAGIT® E 100 (granules) is an immediate-release polymer used as a taste masking, coating agent & film former in tablets, capsules, powders & ODTs.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Amino Methacrylate Copolymer

Dosage Form : Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Amino Methacrylate Copolymer

Dosage Form : Tablet

Category : Controlled & Modified Release

Brand : EUDRAGIT® E 100

Applications : EUDRAGIT® E 100 (granules) is an immediate-release polymer used as a taste masking, coating agent & film former in tablets, capsules, powders & ODTs.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

02

SPI Pharma

U.S.A

World Vaccine Congress

Attending

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Tablet

Grade : Oral

Brand Name : ACTILLETS™

Application : Controlled & Modified Release

Excipient Details : ACTILLETS are microcrystalline cellulose spheres developed using advanced drug delivery technology to enable effective loading & coating of particles.

Pharmacopoeia Ref : NA

Technical Specs :

Ingredient(s) : Microcrystalline Cellulose

Dosage Form : Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Microcrystalline Cellulose

Dosage Form : Tablet

Category : Controlled & Modified Release

Brand : ACTILLETS™

Applications : ACTILLETS are microcrystalline cellulose spheres developed using advanced drug delivery technology to enable effective loading & coating of particles.

Pharmacopoeia Ref : NA

Technical Specs : Not Available

Grade : Oral

03

Evonik

Germany

CPhI WW Frankfurt

Booth #6.1B44

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Tablet

Grade : Oral

Brand Name : EUDRAGIT® L 100

Application : Controlled & Modified Release

Excipient Details : EUDRAGIT® L 100 (powder), a delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : METHACRYLIC ACID COPOLYMER TYPE A

Dosage Form : Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : METHACRYLIC ACID COPOLYMER TYPE A

Dosage Form : Tablet

Category : Controlled & Modified Release

Brand : EUDRAGIT® L 100

Applications : EUDRAGIT® L 100 (powder), a delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

04

Evonik

Germany

CPhI WW Frankfurt

Booth #6.1B44

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Tablet

Grade : Oral

Brand Name : EUDRAGIT® L 100-55

Application : Controlled & Modified Release

Excipient Details : EUDRAGIT® L 100-55 (powder) is used in delayed release coatings to enhance solubility of poorly soluble drugs such as tablets, capsules & granules.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer

Dosage Form : Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer

Dosage Form : Tablet

Category : Controlled & Modified Release

Brand : EUDRAGIT® L 100-55

Applications : EUDRAGIT® L 100-55 (powder) is used in delayed release coatings to enhance solubility of poorly soluble drugs such as tablets, capsules & granules.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

05

Evonik

Germany

CPhI WW Frankfurt

Booth #6.1B44

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Tablet

Grade : Oral

Brand Name : EUDRAGIT® RL 100

Application : Controlled & Modified Release

Excipient Details : EUDRAGIT® RL 100 (granules) is an excipient used as a solubilizer in combination with Eudragit® RS for creating sustained release drugs.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Ammonia Methacrylate Copolymer Type A

Dosage Form : Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Ammonia Methacrylate Copolymer Type A

Dosage Form : Tablet

Category : Controlled & Modified Release

Brand : EUDRAGIT® RL 100

Applications : EUDRAGIT® RL 100 (granules) is an excipient used as a solubilizer in combination with Eudragit® RS for creating sustained release drugs.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

06

Evonik

Germany

CPhI WW Frankfurt

Booth #6.1B44

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Tablet

Grade : Oral

Brand Name : EUDRAGIT® RS 100

Application : Controlled & Modified Release

Excipient Details : EUDRAGIT® RS, a functional sustained release polymer, used in combination with EUDRAGIT® RL for customized release profiles in tablets, capsules, etc.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Ammonio Methacrylate Copolymer Type B

Dosage Form : Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Ammonio Methacrylate Copolymer Type B

Dosage Form : Tablet

Category : Controlled & Modified Release

Brand : EUDRAGIT® RS 100

Applications : EUDRAGIT® RS, a functional sustained release polymer, used in combination with EUDRAGIT® RL for customized release profiles in tablets, capsules, etc.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

07

Evonik

Germany

CPhI WW Frankfurt

Booth #6.1B44

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Tablet

Grade : Oral

Brand Name : EUDRAGIT® S 100

Application : Controlled & Modified Release

Excipient Details : EUDRAGIT® S 100, a delayed release polymer can be combined with other polymers for precise targeting and rapid drug release in tablets, capsules, etc.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Methacrylic Acid Copolymer Type B

Dosage Form : Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Methacrylic Acid Copolymer Type B

Dosage Form : Tablet

Category : Controlled & Modified Release

Brand : EUDRAGIT® S 100

Applications : EUDRAGIT® S 100, a delayed release polymer can be combined with other polymers for precise targeting and rapid drug release in tablets, capsules, etc.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

08

Evonik

Germany

CPhI WW Frankfurt

Booth #6.1B44

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Tablet

Grade : Oral

Brand Name : PlasACRYL® HTP20

Application : Controlled & Modified Release

Excipient Details : PlasACRYL HTP20 is an easy-to-use glidant & plasticizer premix, specifically designed for EUDRAGIT® L 30 D-55 products such as capsules, tablets, etc.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : PLASACRYL HTP20

Dosage Form : Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : PLASACRYL HTP20

Dosage Form : Tablet

Category : Controlled & Modified Release

Brand : PLASACRYL® HTP20

Applications : PlasACRYL HTP20 is an easy-to-use glidant & plasticizer premix, specifically designed for EUDRAGIT® L 30 D-55 products such as capsules, tablets, etc.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

09

Evonik

Germany

CPhI WW Frankfurt

Booth #6.1B44

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Tablet

Grade : Oral

Brand Name : PlasACRYL® T20

Application : Controlled & Modified Release

Excipient Details : PlasACRYL® T20 is an easy-to-use glidant & plasticizer premix, specifically designed for EUDRAGIT® FS 30 D products such as capsules, tablets, etc.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : PLASACRYL T20

Dosage Form : Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : PLASACRYL T20

Dosage Form : Tablet

Category : Controlled & Modified Release

Brand : PLASACRYL® T20

Applications : PlasACRYL® T20 is an easy-to-use glidant & plasticizer premix, specifically designed for EUDRAGIT® FS 30 D products such as capsules, tablets, etc.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

10

Evonik

Germany

CPhI WW Frankfurt

Booth #6.1B44

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Tablet

Grade : Oral

Brand Name : EUDRAGIT® RL 30 D

Application : Controlled & Modified Release

Excipient Details : Eudragit RL 30 D(aqueous dispersion) is a sustained release polymer for customized release profiles, used in combination with EUDRAGIT® RS.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer

Dosage Form : Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer

Dosage Form : Tablet

Category : Controlled & Modified Release

Brand : EUDRAGIT® RL 30 D

Applications : Eudragit RL 30 D(aqueous dispersion) is a sustained release polymer for customized release profiles, used in combination with EUDRAGIT® RS.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

11

Evonik

Germany

CPhI WW Frankfurt

Booth #6.1B44

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Tablet

Grade : Oral

Brand Name : EUDRAGIT® RS PO

Application : Controlled & Modified Release

Excipient Details : EUDRAGIT® RS PO (Powder) is an insoluble sustained release polymer for customized release profiles used in combination with EUDRAGIT® RL.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Ammonio Methacrylate Copolymer Excipient

Dosage Form : Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Ammonio Methacrylate Copolymer Excipient

Dosage Form : Tablet

Category : Controlled & Modified Release

Brand : EUDRAGIT® RS PO

Applications : EUDRAGIT® RS PO (Powder) is an insoluble sustained release polymer for customized release profiles used in combination with EUDRAGIT® RL.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

12

Evonik

Germany

CPhI WW Frankfurt

Booth #6.1B44

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Tablet

Grade : Oral

Brand Name : EUDRAGIT® RS 30 D

Application : Controlled & Modified Release

Excipient Details : EUDRAGIT® RS 30 D(aqueous dispersion) is a sustained release polymer for customized release profiles used in combination with EUDRAGIT® RL.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer

Dosage Form : Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer

Dosage Form : Tablet

Category : Controlled & Modified Release

Brand : EUDRAGIT® RS 30 D

Applications : EUDRAGIT® RS 30 D(aqueous dispersion) is a sustained release polymer for customized release profiles used in combination with EUDRAGIT® RL.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

13

Evonik

Germany

CPhI WW Frankfurt

Booth #6.1B44

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Tablet

Grade : Oral

Brand Name : EUDRAGIT® RS 12,5

Application : Controlled & Modified Release

Excipient Details : EUDRAGIT® RS 12,5 (Organic solution) is a sustained release polymer for customized release profiles used in combination with EUDRAGIT® RL.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer, Methacrylic Acid Excipient

Dosage Form : Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer, Methacrylic Acid Excipient

Dosage Form : Tablet

Category : Controlled & Modified Release

Brand : EUDRAGIT® RS 12,5

Applications : EUDRAGIT® RS 12,5 (Organic solution) is a sustained release polymer for customized release profiles used in combination with EUDRAGIT® RL.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

14

Evonik

Germany

CPhI WW Frankfurt

Booth #6.1B44

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Tablet

Grade : Oral

Brand Name : EUDRAGIT® NE 30 D

Application : Controlled & Modified Release

Excipient Details : Eudragit NE 30 D (aqueous dispersion) is a highly flexible sustained release polymer used for coating (without plasticizer) in OSDs.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer

Dosage Form : Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer

Dosage Form : Tablet

Category : Controlled & Modified Release

Brand : EUDRAGIT® NE 30 D

Applications : Eudragit NE 30 D (aqueous dispersion) is a highly flexible sustained release polymer used for coating (without plasticizer) in OSDs.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

15

Evonik

Germany

CPhI WW Frankfurt

Booth #6.1B44

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Tablet

Grade : Oral

Brand Name : EUDRAGIT® NE 40 D

Application : Controlled & Modified Release

Excipient Details : EUDRAGIT® NE 40 D (aqueous dispersion) is a sustained release polymer used for coating tablets, granules and pellets.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer

Dosage Form : Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer

Dosage Form : Tablet

Category : Controlled & Modified Release

Brand : EUDRAGIT® NE 40 D

Applications : EUDRAGIT® NE 40 D (aqueous dispersion) is a sustained release polymer used for coating tablets, granules and pellets.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

16

BASF

KOLLIDON SR

Pharmex

Not Confirmed

17

Nomisma Healthcare

PLLA-PEG

Pharmex

Not Confirmed

Not Confirmed

Looking for Tablet? Find Controlled & Modified Release & other pharma excipients for Tablet dosage forms on PharmaCompass.

Filters

01

02

03

04

05

06

07

08

09

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

32

33

34

35

36

37

38

39

40

41

42

43

44

45

46

47

48

49

50

51

52

53

54

55